Stockscreener 앱 받기
2.08
5.02%
-0.11
시간 외 거래:
2.39
0.31
+14.90%
Prophase Labs Inc 주식(PRPH)의 최신 뉴스
ProPhase Labs Launches DNA Complete®: Transforming - GlobeNewswire
ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry - StockTitan
ProPhase Labs to Present at the 2024 ThinkEquity Conference - GlobeNewswire
ProPhase Labs projects significant 2025 earnings - Investing.com
ProPhase Labs Announces Positive Updates on Strategic - GlobeNewswire
ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 - StockTitan
Down 34% and 57%, Wall Street Says These 2 Stocks Will Gain 230% - MSN
ProPhase Labs announces change in accounting firm - Investing.com India
ProPhase Labs announces change in accounting firm By Investing.com - Investing.com South Africa
* ProPhase Labs, Inc. Announces final results of its tender offer - Reuters
ProPhase Labs stock hits 52-week low at $2.02 By Investing.com - Investing.com Australia
ProPhase Labs reports non-compliance with Nasdaq rules By Investing.com - Investing.com South Africa
ProPhase Labs reports non-compliance with Nasdaq rules - Investing.com India
ProPhase Labs Seeks Director Amidst Nasdaq Compliance Issue - TipRanks
Priority Technology (NASDAQ:PRTH) Reaches New 1-Year High After Analyst Upgrade - MarketBeat
Primoris Services Co. (NASDAQ:PRIM) Shares Sold by Paradigm Capital Management Inc. NY - Defense World
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Consensus Rating of “Buy” by Analysts - Defense World
Views of Wall Street’s Leading Experts on Proto Labs Inc - SETE News
Tri Locum Partners LP Trims Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat
New underwriter set to launch with ex-Hiscox and AIG leader as chief executive - Insurance Times
Renaissance Technologies LLC Purchases 106,423 Shares of Proto Labs, Inc. (NYSE:PRLB) - Defense World
Transatlantique Private Wealth LLC Buys Shares of 150,000 PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Progyny Stock Faces Its Biggest Drop Ever After Losing a Major Client. Why These Analysts Like the Stock. - Barron's
Mark Sheptoff Financial Planning LLC Purchases New Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Progyny Shares Fall 20% After Announcing It Will Lose 'Significant' Client - MarketWatch
Priority Technology (NASDAQ:PRTH) Hits New 52-Week High at $6.90 - Defense World
Data clang on Street for Prelude but SMARCA2 overtures continue - BioWorld Online
Procaps Issues Shareholder Letter Update - GlobeNewswire
Priority Technology (NASDAQ:PRTH) Shares Gap Up to $6.02 - MarketBeat
Prelude Therapeutics (NASDAQ:PRLD) Receives “Market Outperform” Rating from JMP Securities - Defense World
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - Yahoo Finance
ProPhase Labs, Inc. (NASDAQ:PRPH) Q2 2024 Earnings Call Transcript - MSN
ProPhase Labs secures $10M in amended note agreement By Investing.com - Investing.com Canada
ProPhase Labs secures $10M in amended note agreement - Investing.com
ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event - GlobeNewswire
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Acquired by Vanguard Group Inc. - Defense World
PRPH (ProPhase Labs) Inventory-to-Revenue : 1.54 (As of Jun. 2024) - GuruFocus.com
PRPH (ProPhase Labs) Ending Cash Position : $2.37 Mil (As of Jun. 2024) - GuruFocus.com
PRPH (ProPhase Labs) Machinery, Furniture, Equipment : $0.00 Mil (As of Jun. 2024) - GuruFocus.com
PRPH (ProPhase Labs) Quick Ratio : 1.44 (As of Jun. 2024) - GuruFocus.com
PRPH (ProPhase Labs) Volatility : 80.80% (As of Aug. 16, 2024) - GuruFocus.com
PRPH (ProPhase Labs) Net Income From Continuing Operations : $-26.31 Mil (TTM As of Jun. 2024) - GuruFocus.com
PRPH (ProPhase Labs) COGS-to-Revenue : 1.19 (As of Jun. 2024) - GuruFocus.com
ProPhase Labs Inc (PRPH) Q2 2024 Earnings Call Transcript Highli - GuruFocus.com
ProPhase Labs stock hits 52-week low at $2.31 amid market challenges - Investing.com
ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024 - GlobeNewswire
Earnings call: ProPhase Labs focuses on growth amid seasonal challenges By Investing.com - Investing.com India
Earnings call: ProPhase Labs focuses on growth amid seasonal challenges - Investing.com
PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace
ProPhase Labs partners with FHC for cancer test rollout - Investing.com
ProPhase Labs Q2 2024 Earnings Preview - MSN
ProPhase Labs partners with FHC for cancer test rollout By Investing.com - Investing.com Australia
ProPhase Labs Announces Collaboration with Forward - GlobeNewswire
ProPhase Labs Announces Collaboration with Forward Healthcare Consultants to Aid in the Commercialization of its Billion Dollar Potential BE-Smart Esophageal Cancer Test - GlobeNewswire
ProPhase Labs (PRPH) Set to Announce Quarterly Earnings on Wednesday - Defense World
Antibody Production Market to Surpass USD 36.49 Billion by 2032 Driven by Escalating Demand for Targeted Therapies and Technological Advancements | Research by SNS Insider - GlobeNewswire Inc.
PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14 - StockTitan
3.48%
0.04%
자본화:
|
볼륨(24시간):